Clinical efficacy and safety outcomes of bempedoic acid: An updated systematic review and meta-analysis after CLEAR Outcomes trial

Clinical efficacy and safety outcomes of bempedoic acid: An updated systematic review and meta-analysis after CLEAR Outcomes trial

Purpose: Statins are the cornerstone therapy for primary or secondary prevention of atherosclerotic cardiovascular disease (ASCVD). However, a significant portion of patients are intolerant to statin or show inadequate lipid-lowering. Bempedoic acid (BA) has been shown to decrease low-density lipopr...

Full description

Bibliographic Details
Main Authors:	Amit Bhandari, Prakash Raj Oli, Dhan Bahadur Shrestha, Sagun Dawadi, Bishnu Deep Pathak, Manoj Bhandari, Yub Raj Sedhai, Bibhusan Basnet, Laxmi Regmi, Aniruddha Singh, Nimesh K. Patel
Format:	Article
Language:	English
Published:	Elsevier 2023-12-01
Series:	Health Sciences Review
Subjects:	Bempedoic acid Statin Statin intolerance Atherosclerotic cardiovascular diseases Hyperlipidemia
Online Access:	http://www.sciencedirect.com/science/article/pii/S2772632023000429

Similar Items

The Pathogenetic Basis of the Action of Bempedoic Acid
by: A. S. Petrosyan, et al.
Published: (2023-01-01)

CLEAR Serenity Trial: More Clarity for the Future of Bempedoic Acid in Patients Unable to Take Statins?
by: Xiaoming Jia, et al.
Published: (2019-04-01)

Case report: Strong low-density-cholesterol reduction accompanied by shrinkage of low-attenuation coronary plaque during lipid-lowering treatment with bempedoic acid—serial evaluation by coronary computed tomography angiography
by: Grigorios Korosoglou, et al.
Published: (2023-08-01)

Bempedoic Acid: An Emerging Therapy for Uncontrolled Low-Density Lipoprotein (LDL) Cholesterol
by: Akshyaya Pradhan, et al.
Published: (2023-04-01)

Mechanism of action and therapeutic use of bempedoic acid in atherosclerosis and metabolic syndrome
by: Gianni Biolo, et al.
Published: (2022-10-01)

Factors Associated With Enhanced Low‐Density Lipoprotein Cholesterol Lowering With Bempedoic Acid
by: Christie M. Ballantyne, et al.
Published: (2022-08-01)

Efficacy and safety of bempedoic acid alone or combining with other lipid-lowering therapies in hypercholesterolemic patients: a meta-analysis of randomized controlled trials
by: Xiang Zhao, et al.
Published: (2020-12-01)

Executive summary of the Hellenic Atherosclerosis Society guidelines for the diagnosis and treatment of dyslipidemias - 2023
by: N Katsiki, et al.
Published: (2024-03-01)

Emerging Therapies for the Treatment of Atherosclerotic Cardiovascular Disease: From Bench to Bedside
by: Marko Kumric, et al.
Published: (2023-04-01)

Bempedoic Acid: Safety and Efficiacy of a New Lipid-Lowering Agent
by: I. A. Mazerkina, et al.
Published: (2023-09-01)

Atherosclerosis and Statins
by: Marzieh Shahrezaei, et al.
Published: (2011-07-01)

Effects of Bempedoic Acid in Acute Myocardial Infarction in Rats: No Cardioprotection and No Hidden Cardiotoxicity
by: Tamás G. Gergely, et al.
Published: (2023-01-01)

Severe hypertriglyceridemia after use of bempedoic acid
by: Valentin Bovy, et al.
Published: (2023-04-01)

Bempedoic acid: mechanism of action and therapeutic use in atherosclerotic cardiovascular diseases and diabetes
by: V.A. Serhiyenko, et al.
Published: (2023-05-01)

Low-Density Lipoprotein Cholesterol-Lowering Drugs: A Narrative Review
by: Nicola Ferri, et al.
Published: (2024-02-01)

Statin efficacy in the treatment of hepatitis C genotype I
by: Ahmad Shavakhi, et al.
Published: (2014-01-01)

Novel and Emerging LDL-C Lowering Strategies: A New Era of Dyslipidemia Management
by: Federica Agnello, et al.
Published: (2024-02-01)

Natural language processing to identify reasons for sex disparity in statin prescriptions
by: Celeste Witting, et al.
Published: (2023-06-01)

The effects of hyperlipidemia on rotator cuff diseases: a systematic review
by: Yang Yang, et al.
Published: (2018-08-01)

Shared Decisions: A Qualitative Study on Clinician and Patient Perspectives on Statin Therapy and Statin‐Associated Side Effects
by: Sarah T. Ahmed, et al.
Published: (2020-11-01)

Bempedoic acid for the treatment of dyslipidemia
by: Joel C Marrs, et al.
Published: (2020-08-01)

Low-density lipoprotein cholesterol outcomes post-non-PCSK9i lipid-lowering therapies in atherosclerotic cardiovascular disease and probable heterozygous familial hypercholesterolemia patients
by: Chen CC, et al.
Published: (2018-12-01)

Impact of oral statin therapy on clinical outcomes in patients with cT1 breast cancer
by: Koji Takada, et al.
Published: (2023-03-01)

The Impact of Age on Statin-Related Glycemia: A Propensity Score-Matched Cohort Study in Korea
by: Shaopeng Xu, et al.
Published: (2022-04-01)

10-YEAR RISK ESTIMATION OF ATHEROSCLEROTIC CARDIOVASCULAR DISEASE IN HYPERTENSIVE PATIENTS
by: Olha M. Chernatska, et al.
Published: (2021-06-01)

Rapid Regression of Carotid Artery Stenosis Shortly after Intensive Medical Therapy
by: Suh Yeon Park, et al.
Published: (2022-02-01)

The Comparison of Penile Doppler Ultrasonography Findings with Serum Lipid Parameters in Hyperlipidemic Patients with Erectile Dysfunction
by: Mustafa Tasdemir, et al.
Published: (2021-05-01)

Self- vs provider-referral differences for coronary artery calcium testing
by: Rebekah Lantz, et al.
Published: (2022-01-01)

Judicious Use of Lipid Lowering Agents in the Management of NAFLD
by: Umair Iqbal, et al.
Published: (2018-09-01)

Statin drugs mitigate cellular inflammatory response after ST elevation myocardial infarction, but do not affect in-hospital mortality
by: Leili Pourafkari, et al.
Published: (2016-03-01)

High-potency statins but not all statins decrease the risk of new-onset osteoporotic fractures: a nationwide population-based longitudinal cohort study
by: Lin TK, et al.
Published: (2018-01-01)

Safety and efficacy of bempedoic acid: a systematic review and meta-analysis of randomised controlled trials
by: Ovidio De Filippo, et al.
Published: (2023-11-01)

Bempedoic acid and its role in contemporary management of hyperlipidemia in atherosclerosis
by: Ramyashree Tummala, et al.
Published: (2022-12-01)

Beneficial effects of bempedoic acid treatment in polycystic kidney disease cells and mice
by: Kenneth R. Hallows, et al.
Published: (2022-11-01)

Efficacy and Safety of Bempedoic Acid in Patients With Hypercholesterolemia and Statin Intolerance
by: Ulrich Laufs, et al.
Published: (2019-04-01)

Efficacy and Safety of Bempedoic Acid in Patients With Hypercholesterolemia: Systematic Review and Meta‐Analysis of Randomized Controlled Trials
by: Alessandro Di Minno, et al.
Published: (2020-08-01)

Efficacy and safety of bempedoic acid for prevention of cardiovascular events and diabetes: a systematic review and meta-analysis
by: Xing Wang, et al.
Published: (2020-08-01)

KHK, PNPLA3 and PPAR as Novel Targets for the Anti-Steatotic Action of Bempedoic Acid
by: Ana Magdalena Velázquez, et al.
Published: (2022-06-01)

Evaluation of Statin Indication and Dose Intensification Among Type 2 Diabetic Patients at a Tertiary Hospital
by: Fisseha PY, et al.
Published: (2024-03-01)

Statin Use and Eligibility for Primary Prevention of Atherosclerotic Cardiovascular Disease Among Adults at Borderline or Intermediate Risk in the United States
by: Michael M. Hammond, et al.
Published: (2023-04-01)